RayStation® will be extended to include treatment planning for the TomoTherapy® and CyberKnife® Systems
RaySearch Laboratories AB (publ) (NASDAQ OMX Stockholm: RAY B) and Accuray Incorporated (Nasdaq: ARAY) announced today
that they have expanded on their existing relationship with the signing of a new long-term collaboration agreement,
which will lead to the integration of treatment planning support for the TomoTherapy® and CyberKnife® Systems in the
RayStation® treatment planning system (TPS). RayStation is one of the most advanced independent treatment planning
systems available and will provide an ideal complement to the unique Accuray treatment delivery systems, enabling
customers to choose the delivery technology that will best meet their needs. Accuray and RaySearch previously announced
a long-term collaboration regarding the RayCare® oncology information system.
“This agreement marks an important progression in our partnership with RaySearch. We believe the integration of their
industry-leading TPS along with our innovative treatment delivery systems will enable clinicians to further optimize
their experience and use of Accuray technology long-term,” said Joshua H. Levine, president and chief executive officer
of Accuray. “Our goal is to maximize the clinical effectiveness of our Systems and enhance the ease with which they
integrate within the radiation oncology department. We are pursuing multiple paths to achieve this result, including
this agreement with RaySearch, which will provide both flexibility and enhanced options for our customers.”
Under the contract, Accuray will have the opportunity to offer RayStation to clinicians who use the TomoTherapy and
CyberKnife System product portfolios. Current RayStation users report that the software provides multiple benefits
including advanced treatment planning tools, leading workflow support and an excellent user experience, all of which
enhance treatment delivery flexibility within a radiation oncology department.
Accuray has an installed base of more than 500 TomoTherapy Systems and more than 300 CyberKnife Systems worldwide.
Treatment planning support for TomoTherapy Systems in RayStation is targeted for release during 2016 and support for
CyberKnife Systems for release during 2017.
“This agreement with Accuray enables us to expand our relationship with a like-minded company committed to improving the
way radiation therapy is delivered,” said Johan Löf, president and chief executive officer of RaySearch Laboratories AB
(publ). “For the first time ever, treatment planning for both of the Accuray systems as well as conventional linear
accelerators will be available in one integrated treatment planning system. This integration alone will entail
significant gains in efficiency for clinics that have several machine types. Additionally, we see that many of
RayStation’s unique strengths are exceptionally well suited to the Accuray systems. In summary, we think that this
collaboration will strengthen both RayStation’s and the Accuray systems’ competitiveness.”
ENDS